Step Pharma S.A.S.
Records under this name other than the patents Step Pharma S.A.S. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 10 of 10 · Back to Step Pharma S.A.S.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,987,573 | Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors now held by Sygnature Discovery Limited In force · High confidence | In force | High confidence | |
| 16/982,641 | Compounds Abandoned Abandoned Nov 9, 2022 | Abandoned | Abandoned Nov 9, 2022 | |
| 17/615,879 | N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases Abandoned Abandoned Feb 18, 2026 | Abandoned | Abandoned Feb 18, 2026 | |
| 17/760,861 | Sulfonamide Derivatives as CTPS1 Inhibitors Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 17/980,186 | Compositions Related to Substituted Pyrazines as CTPS Inhibitors Abandoned Abandoned Aug 15, 2025 | Abandoned | Abandoned Aug 15, 2025 | |
| 18/842,972 | Combinations of CTPS1 and BCL2 Inhibitors for Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/140,541 | CTPS1 Inhibitors for Use in the Treatment of CTPS2 Deficient Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/203,129 | Compounds Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/217,739 | Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/357,600 | N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |